← Back to Discover
Lion Point Capital, LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $20,905,264
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CUE BIOPHARMA INC · COM · 22978P205 · shares: $1,670,408
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $1,489,816
- MOONLAKE IMMUNOTHERAPEUTICS · CLASS A ORD · 61559X104 · shares: $1,314,225
- FENNEC PHARMACEUTICALS INC · COM · 31447P100 · shares: $1,208,666
- ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104 · shares: $1,199,898
- COMPASS PATHWAYS PLC · SPONSORED ADS · 20451W101 · shares: $1,132,000
- MILESTONE PHARMACEUTICALS IN · COM · 59935V107 · shares: $1,098,800
- BENITEC BIOPHARMA INC · COM NEW · 08205P209 · shares: $829,560
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $786,960
- BIOHAVEN LTD · COM · G1110E107 · shares: $769,296
Reported holdings
35 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CUE BIOPHARMA INC | COM | 22978P205 | — | 52,928 shares | $1,670,408 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 4,450 shares | $1,489,816 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 67,500 shares | $1,314,225 |
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | — | 112,434 shares | $1,208,666 |
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | — | 21,400 shares | $1,199,898 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 80,000 shares | $1,132,000 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | — | 820,000 shares | $1,098,800 |
| BENITEC BIOPHARMA INC | COM NEW | 08205P209 | — | 62,000 shares | $829,560 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 36,000 shares | $786,960 |
| BIOHAVEN LTD | COM | G1110E107 | — | 51,700 shares | $769,296 |
| GERON CORP | COM | 374163103 | — | 578,000 shares | $739,840 |
| UNIQURE NV | SHS | N90064101 | — | 14,700 shares | $677,082 |
| ARDELYX INC | COM | 039697107 | — | 128,650 shares | $656,115 |
| LANTHEUS HLDGS INC | COM | 516544103 | — | 5,500 shares | $610,170 |
| DISC MEDICINE INC | COM | 254604101 | — | 8,100 shares | $592,434 |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | — | 28,500 shares | $512,145 |
| HUMACYTE INC | COM | 44486Q103 | — | 650,000 shares | $507,260 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 46,000 shares | $504,620 |
| VIATRIS INC | COM | 92556V106 | — | 27,700 shares | $439,876 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 18,000 shares | $399,780 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 5,000 shares | $372,400 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 9,100 shares | $369,733 |
| PACIRA BIOSCIENCES INC | COM | 695127100 | — | 13,500 shares | $342,495 |
| REGENXBIO INC | COM | 75901B107 | — | 26,600 shares | $318,668 |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | — | 86,000 shares | $294,120 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 19,000 shares | $291,840 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 10,500 shares | $283,290 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 10,200 shares | $274,176 |
| SERES THERAPEUTICS INC | COM NEW | 81750R201 | — | 31,570 shares | $249,087 |
| AZENTA INC | COM | 114340102 | — | 9,700 shares | $247,544 |
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | — | 465,000 shares | $195,765 |
| INNOVIVA INC | COM | 45781M101 | — | 8,200 shares | $186,222 |
| INNATE PHARMA S A | SPONSORED ADS | 45781K204 | — | 81,151 shares | $149,318 |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | — | 5,250 shares | $137,655 |
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | — | 1,000 shares | $54,000 |